Magle Group

We are Magle Group

We are happy to announce that Magle Chemoswed has successfully gone through an annual audit of its ISO 13485:2016 quality system for the development and manufacturing of medical devices. The scope of the extended Quality Management system covers: Design,

Magle Chemoswed has been fatured in Dagens Industri as a part of the Almedalsveckan supplement. Click below to read the full article (in Swedish). Read more

The Quality Management System of Magle Chemoswed har been transformed from a traditional GMP system to a bilingual system also addressing the requirements of ISO 13485:2016 for Medical devices. After passing a successful onsite audit the ISO 13485 certifi

As a part of the efforts to modernize, Magle Chemoswed has invested in new modular facilites to be placed on the production facility site. We are happy to announce that planning permission has been granted by Malmö Stad and that our move from the Celsiusg

Magle Chemoswed has received positive responses from regulatory agencies for market authorization of its range of advanced wound care products. This provides us with a clear pathway to registration of these developed products. As a strategic market for th

Magle Chemoswed expands its sales of Benserazide to a key customer as part of the Company strategy to enter emerging markets. The sale of Benserazide is testament to our strong commitment to make a difference in the field of healthcare and responsibly exp

Magle Chemoswed has filed multi-jurisdictional patent applications for protection for our range of surgical diagnostic devices. This is a first-in-class invention under which we have chemically bound enzymatic indicators to our SmartSpheres to be used by

MCS receives approval from the United States patent authorities on its microsphere technology

MCS's SmartGel successfully moves to final phase for testing before regulatory approval.